Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Impact
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Advise on our research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Research looks into bringing an end to the spread of breast cancer to other parts of the body

Research looks into bringing an end to the spread of breast cancer to other parts of the body

Date time 19 January, 2016
News Type News type Media release

Breast cancer continues to be one of the major causes of death in Australian women, but research being undertaken in Camperdown, by Centenary Institute cancer researcher Dr Shweta Tikoo, is hoped to identify new therapeutic targets aimed at preventing the spread of this cancer to other parts of the body.

It is estimated that last year more than 3,000 Australian women succumbed to breast cancer, and Dr Tikoo has been awarded funding from Cancer Australia to investigate the underlying mechanisms that drive the spread of breast cancer.

While primary breast cancer can be treated through surgery and chemotherapy, the prognosis can be much poorer once the cancer spreads to other organs.

Dr Shweta Tikoo has been awarded funding from Cancer Australia to research breat cancer.

This is due in part to the rapid development of chemotherapy resistance in metastatic breast cancer cells.

Dr Tikoo said this new research project will investigate the role of “Perivascular Macrophages” in tumour cell metastasis.

Macrophages are a type of immune cells which have been widely implicated in tumour progression and metastasis.

“If we can understand the spread of breast cancer at cellular and molecular level, we can develop new therapeutic targets to intervene in the process,” Dr Tikoo said.

“This funding support from Cancer Australia will enable us to take a new and inventive approach to understanding and treating breast cancer, which will hopefully improve the patient outcome in future.”

Click here to see the article on the News Local website

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Download

Recent Stories

  • Centenary researchers aim to improve diagnosis of heavy menstrual bleeding

    The Centenary Institute is implementing a new research program aimed at improving the diagnosis and care of women experiencing heavy menstrual bleeding.
    News Type: Research News
    Date 21 May 2026
  • New insight into liver ‘cross-talk’ could help tackle fatty liver disease

    Researchers from the Centenary Institute and Tianjin Medical University have uncovered an important communication pathway inside the liver that helps control fat build-up, offering a promising new direction for tackling fatty liver disease.
    News Type: Research News
    Date 13 May 2026
  • Blood clotting protein’s hidden complexity revealed

    Researchers at the Centenary Institute have discovered that fibrinogen, a key blood clotting protein, is far more complex than previously understood, offering new insight into how blood clots form in the body.
    News Type: Research News
    Date 30 Apr 2026
  • Researcher spotlight: Dr Tracy Liu

    For Dr Xin (Tracy) Liu, fatty liver disease isn’t just a scientific challenge, it’s personal. Inspired by family members affected by metabolic conditions, she’s now a key member of Australia’s seven‑year Snow Program for Liver Health.
    News Type: Profiles
    Date 24 Apr 2026

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram